Td Private Client Wealth LLC Astrazeneca PLC Transaction History

Td Private Client Wealth LLC

$3.48 Trillion
Q3 2024

A detailed history of Td Private Client Wealth LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Td Private Client Wealth LLC holds 10,607 shares of AZN stock, worth $695,500. This represents 0.02% of its overall portfolio holdings.

Number of Shares

10,607

Previous 12,008 11.67%

Holding current value

$695,500

Previous $937 Million 11.76%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 18, 2024	SELL	$76.67 - $87.62 $107,414 - $122,755	-1,401 Reduced 11.67%	10,607 $826 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $802,254 - $970,606	12,008 New	12,008 $937 Million
Q1 2024 Aug 16, 2024	SELL	$61.03 - $69.57 $1,159 - $1,321	-19 Reduced 0.14%	13,392 $907 Million
Q4 2023 Aug 16, 2024	BUY	$61.89 - $69.28 $60,590 - $67,825	979 Added 7.87%	13,411 $903 Million
Q3 2023 Aug 16, 2024	SELL	$64.85 - $71.7 $210,178 - $232,379	-3,241 Reduced 20.68%	12,432 $842 Million
Q2 2023 Aug 16, 2024	SELL	$69.91 - $75.81 $117,728 - $127,664	-1,684 Reduced 9.7%	15,673 $1.12 Billion
Q1 2023 Aug 16, 2024	SELL	$63.15 - $71.6 $547,068 - $620,270	-8,663 Reduced 33.29%	17,357 $1.2 Billion
Q4 2022 Aug 16, 2024	BUY	$54.21 - $70.44 $5,475 - $7,114	101 Added 0.39%	26,020 $1.76 Billion
Q3 2022 Aug 16, 2024	SELL	$53.02 - $135.75 $86,210 - $220,729	-1,626 Reduced 5.9%	25,919 $1.42 Billion
Q2 2022 Aug 16, 2024	SELL	$59.26 - $71.14 $78,875 - $94,687	-1,331 Reduced 4.61%	27,545 $1.82 Billion
Q1 2022 Aug 16, 2024	BUY	$55.72 - $67.12 $50,148 - $60,408	900 Added 3.22%	28,876 $1.92 Billion
Q4 2021 Aug 16, 2024	BUY	$54.02 - $63.83 $189,178 - $223,532	3,502 Added 14.31%	27,976 $1.63 Billion
Q3 2021 Aug 16, 2024	BUY	$55.56 - $60.79 $692,610 - $757,808	12,466 Added 103.81%	24,474 $1.47 Billion
Q2 2021 Aug 16, 2024	BUY	$48.42 - $60.18 $165,063 - $205,153	3,409 Added 17.28%	23,142 $1.39 Billion
Q1 2021 Aug 16, 2024	BUY	$47.16 - $54.44 $11,601 - $13,392	246 Added 1.26%	19,733 $981 Million
Q4 2020 Aug 16, 2024	BUY	$48.52 - $58.02 $19,505 - $23,324	402 Added 2.11%	19,487 $974 Million
Q3 2020 Aug 16, 2024	SELL	$53.07 - $61.1 $476,727 - $548,861	-8,983 Reduced 32.0%	19,085 $1.05 Billion
Q2 2020 Aug 16, 2024	BUY	$43.1 - $55.31 $56,935 - $73,064	1,321 Added 4.94%	28,068 $1.48 Billion
Q1 2020 Aug 16, 2024	BUY	$37.79 - $51.33 $163,328 - $221,848	4,322 Added 19.27%	26,747 $1.19 Billion
Q4 2019 Aug 16, 2024	BUY	$42.46 - $50.46 $442,305 - $525,641	10,417 Added 86.75%	22,425 $1.12 Billion

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Astrazeneca PLC Transaction History